Development of a human antibody fragment directed against the alpha folate receptor as a promising molecule for targeted application

Alpha folate receptor (FRα) is currently under investigation as a target for the treatment of patients with non-small-cell lung cancer (NSCLC), since it is highly expressed in tumor cells but is largely absent in normal tissue. In this study, a novel human variable domain of a heavy-chain (VH) antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Parakasikron, Nattihda, Chaotham, Chatchai, Chanvorachote, Pithi, Vinayanuwattikun, Chanida, Buranasudja, Visarut, Taweecheep, Pornchanok, Khantasup, Kannika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274507/
https://www.ncbi.nlm.nih.gov/pubmed/34236266
http://dx.doi.org/10.1080/10717544.2021.1943055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274507/
https://www.ncbi.nlm.nih.gov/pubmed/34236266
http://dx.doi.org/10.1080/10717544.2021.1943055

Ejemplares similares